Financial advisers shun Noveko, despite record demand

Home » Media Mentions » Financial advisers shun Noveko, despite record demand

May 9, 2009

The proliferation of influenza A/H1N1 has led to an explosion of orders for antimicrobial filters for respiratory masks manufactured by Noveko International (Tor., EKO, $ 1.80).

Read this French article on Les Affaires…

Claret

Author

Claret
Claret Asset Management specializes in offering portfolio management services to high net worth clients. We are completely independent and free of conflicts of interest. Claret was founded in 1996 with the objective of answering the growing needs of private investors.

You may also enjoy:

How Are the Markets Doing?

What are REITs? Real Estate Investment Trusts, Explained

P/E Ratio: Price-to-Earnings Ratio Explained

3 Trading Order Types Explained

Should We Rethink the 4% Rule? Debunking Dave Ramsey